Search results
Results from the WOW.Com Content Network
Founded in 2005, Parsemus is an advocate of research into the plausibility of RISUG (and a method based on RISUG, called Vasalgel), a reversible male contraceptive. [2] [3] The foundation began procuring RISUG's United States intellectual property rights in November 2010, completed the acquisition process in February 2012, and is for the past 8 years conducting toxicology tests as an initial ...
Beginning in 2011, a contraceptive product based on RISUG, Vasalgel, was under development in the US by the Parsemus Foundation, who were unable to bring the product to market over the next decade. [3] In 2023, the patent for Vasalgel was acquired by NEXT Life Sciences, which plans to bring the technology to market under the name Plan A for Men ...
If Treasury yields continue to rise, either stock prices need to fall or companies need to produce bigger profit growth to make up for it. All told Tuesday, the S&P 500 rose 6.69 points to 5,842.91.
Yet, investors are overlooking this guidance as the stock is performing well today. Other stocks rising in the Dow include Caterpillar, Boeing, Home Depot, and UnitedHealth.
Every morning for a year and a half, Logan Whitehead, 24, rubbed a clear gel on his shoulders, waited for it to dry, then went about his day as usual.
Vasalgel was successful in achieving azoospermia in rabbits within 36 days of injection, as well as returned vas deferens patency. [9] In 2023, the patent for Vasalgel was acquired by NEXT Life Sciences , Inc., which plans to bring the technology to market under the name Plan A for Men .
Stock market today: Dow, S&P 500, Nasdaq slide as inflation, tariff fears push stocks to another losing week. Yahoo Finance. Oil posts weekly loss as US-China trade war sparks demand concerns.
Good news on the U.S. economy is back to being bad for Wall Street, and the stock market slumped Tuesday following better-than-expected reports on the job market and business activity. The S&P 500 ...